Geneva’s position as a leading European life science hub makes it the ideal choice for Connect in Pharma
06 June, 2023
The Intabio ZT system is the first available system to fully integrate icIEF-UV and mass spectrometry
05 June, 2023
London, UK, 5 June 2023, BenevolentAI (Euronext Amsterdam: BAI), a leader in the development of cutting-edge AI that accelerates biopharma discovery, announces the successful delivery of its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS), BEN-34712.
05 June, 2023
The home of the UK’s lab industry expands floor plan to accommodate increased interest in this year’s show
05 June, 2023